Alma expands injectables presence in APAC with launch of Profhilo in Thailand

Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has announced the opening of its new subsidiary in Thailand, alongside the launch of Profhilo, a groundbreaking dermal bio-remodeler exclusively distributed by the company in Thailand.

Recently approved by the Thailand Food and Drug Administration (TFDA) for use on the face and neck, Profhilo is indicated for remodeling laxity and supporting dermal tissue repair in cases of acne scars. Now available to Thai practitioners, it sets a new benchmark for high-quality aesthetic care for both doctors and patients.

The flagship Swiss-based bio-remodeler, Profhilo, delivers a unique "beneath-the-skin" hyaluronic acid treatment, powered by patented NAHYCO technology. This advanced formulation provides a prolonged stimulating effect on dermal cells, rejuvenating the skin by improving laxity, skin quality and restoring firmness.

Unlike traditional wrinkle treatments or dermal fillers, Profhilo works by stimulating collagen and elastin production while deeply hydrating the skin, resulting in natural, long-lasting improvements in skin quality.

Alma's new Thailand office and the seventh Asia Pacific subsidiary, will serve as a strategic hub, supporting the company's growing presence in Southeast Asia—a region rapidly establishing itself as a global leader in aesthetics. Thailand, in particular, holds major potential as one of the most dynamic economies in the region and a thriving market for aesthetic treatments. The market value of the injectable segment in Thailand has also soared significantly, reaching an estimated 57 billion Thai Baht in recent years.